Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urine Vilanterol Thresholds in Athletes
NCT03739294Phase 2Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Feb 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of vilanterol trifenatate in asthma (6 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Urine concentrations of vilanterol and its metabolites at 72 hours. Started Feb 2019; status: completed.
02
Drugs
vilanterol trifenatate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03739294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03739294.